Screener › Biotech Small Cap Stocks
Biotech Small Cap Stocks
Small and micro cap biotech stocks under $5B market cap — high-risk, high-reward pipeline plays in gene therapy, oncology, rare diseases, and precision medicine.
| Ticker | Société | Cours | Capitalisation | Potentiel | Pos. 52sem. | Smart Money |
|---|---|---|---|---|---|---|
| STVN | Stevanato Group | $16.96 -3.31% | $4.63B | 44.2% | 26.9% | — |
| FOLD | Amicus Therapeutics | $14.49 +0% | $4.55B | 0.1% | 99.9% | — |
| INDV | Indivior Pharmaceuticals, Inc. | $38.32 +0.05% | $4.53B | 32.3% | 90.3% | — |
| SHC | Sotera Health Company | $15.74 -0.51% | $4.49B | 27.8% | 54% | — |
| ALHC | Alignment Healthcare | $21.29 -2.61% | $4.4B | 17.1% | 78.9% | — |
| RDNT | RadNet, Inc. | $55.76 +3.76% | $4.38B | 61% | 14.3% | — |
| LIVN | LivaNova PLC | $78.71 +0.27% | $4.32B | 2.4% | 94.4% | — |
| VCYT | Veracyte, Inc. | $53.19 -0.82% | $4.24B | -7.7% | 95.2% | — |
| NVST | Envista Holdings | $25.50 -1.6% | $4.15B | 16.5% | 59.3% | — |
| MMSI | Merit Medical Systems | $66.50 -1.07% | $3.97B | 34.7% | 18.3% | — |
| EWTX | Edgewise Therapeutics | $36.50 -0.84% | $3.93B | 32% | 85.1% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. | $31.38 +0% | $3.84B | 0.9% | 91.3% | — |
| DNLI | Denali Therapeutics | $24.05 +3.17% | $3.82B | 41.1% | 95.1% | — |
| ACAD | Acadia Pharmaceuticals | $22.09 +2.17% | $3.78B | 43.3% | 27.7% | — |
| VKTX | Viking Therapeutics | $32.37 +6.55% | $3.76B | 186% | 46.6% | — |
| DOCS | Doximity, Inc. | $20.07 -1.91% | $3.67B | 26.7% | 4.9% | — |
| BEAM | Beam Therapeutics | $35.53 +4.07% | $3.66B | 43.7% | 93.7% | — |
| CON | Concentra Group Holdings Parent | $28.49 -0.25% | $3.65B | 10.6% | 95.7% | — |
| FIE.DE | Fielmann | $43.40 -0.12% | $3.64B | 35.7% | 18.7% | — |
| OGN | Organon & Co. | $13.40 -0.22% | $3.52B | -16% | 98.8% | — |
| LFST | LifeStance Health Group, Inc. | $9.21 +2.51% | $3.51B | 14.6% | 98.5% | — |
| IRTC | iRhythm Technologies | $104.69 +0.04% | $3.44B | 70.9% | 3.5% | — |
| RCUS | Arcus Biosciences, Inc. | $27.23 +12.01% | $3.42B | 31.3% | 92.8% | — |
| ICUI | ICU Medical, Inc. | $136.14 -3.01% | $3.4B | 26.7% | 54.7% | — |
| OPCH | Option Care Health, Inc. | $21.30 -3.14% | $3.34B | 34.2% | 17.5% | — |
| ARQT | Arcutis Biotherapeutics | $26.66 +1.72% | $3.33B | 29.9% | 72.7% | — |
| WAY | Waystar Holding Corp. | $17.31 -6.28% | $3.32B | 95.4% | 0.2% | — |
| HAE | Haemonetics Corporation | $72.53 -2.21% | $3.3B | 17.5% | 63% | — |
| NHC | National HealthCare Corporation | $201.40 -0.06% | $3.15B | — | 96% | — |
| ITGR | Integer Holdings Corporation | $90.10 -0.95% | $3.06B | 8.3% | 45.5% | — |
| SFZN.SW | Siegfried Holding | $68.55 +0.88% | $3B | 44.7% | 9.6% | — |
| PRVA | Privia Health Group, Inc. | $23.49 -0.76% | $2.96B | 33.8% | 61% | — |
| VIRP.PA | Virbac | $338.00 -0.73% | $2.83B | 22.2% | 44.9% | — |
| CLDX | Celldex Therapeutics | $33.41 +3.02% | $2.62B | 72.2% | 85.4% | — |
| TMDX | TransMedics Group | $75.51 -4.16% | $2.61B | 55.4% | 16.1% | — |
| SUPN | Supernus Pharmaceuticals, Inc. | $44.48 +0.23% | $2.58B | 41.3% | 47.3% | — |
| ACHC | Acadia Healthcare Company, Inc. | $25.21 +1.37% | $2.32B | 14.5% | 73.4% | — |
| DMP.DE | Dermapharm Holding | $46.55 +0% | $2.31B | 8.2% | 73.5% | — |
| NKTR | Nektar Therapeutics | $65.70 +7.74% | $2.22B | 133.3% | 57% | — |
| OCUL | Ocular Therapeutix | $9.97 +5.73% | $2.18B | 169.9% | 36.6% | — |
| PBH | Prestige Consumer Healthcare In | $45.51 -3.11% | $2.16B | 46.8% | 6.8% | — |
| AGIO | Agios Pharmaceuticals | $35.10 +2.75% | $2.09B | 16.1% | 54.1% | — |
| ZLAB | Zymeworks | $18.48 +1.65% | $2.08B | 80.2% | 10% | — |
| VCEL | Vericel Corporation | $40.47 +0.92% | $2.07B | 37% | 78.8% | — |
| PGNY | Progyny, Inc. | $26.28 +0.77% | $2.06B | 13.1% | 80.5% | — |
| SEM | Select Medical Holdings Corpora | $16.54 +0% | $2.05B | 0.5% | 91.6% | — |
| XRAY | DENTSPLY SIRONA Inc. | $10.15 -1.74% | $2.03B | 32% | 9.6% | — |
| LMAT | LeMaitre Vascular | $88.61 -5.68% | $2.02B | 34% | 24.6% | — |
| ADMA | ADMA Biologics | $8.57 +3.13% | $1.99B | 105.4% | 10.3% | — |
| ASTH | Astrana Health Inc. | $39.59 +1.07% | $1.96B | 16.2% | 95.6% | — |
| NEOG | Neogen Corporation | $8.92 -4.19% | $1.94B | 34.5% | 63.5% | — |
| HRMY | Harmony Biosciences Holdings, I | $33.43 +0.45% | $1.94B | 32.7% | 51.5% | — |
| MD | Pediatrix Medical Group, Inc. | $23.52 -0.38% | $1.93B | -1.5% | 88.8% | — |
| TECN.SW | Tecan Group | $150.40 -0.86% | $1.9B | 10% | 59.5% | — |
| SRPT | Sarepta Therapeutics | $17.65 +0.68% | $1.86B | 24.7% | 48.5% | — |
| ANIP | ANI Pharmaceuticals, Inc. | $80.58 +1.37% | $1.83B | 39.9% | 48.7% | — |
| DVAX | Dynavax Technologies | $15.50 +0% | $1.82B | 3.2% | 50% | — |
| IOVA | Iovance Biotherapeutics | $4.06 +3.84% | $1.81B | 116.8% | 60.5% | — |
| UFPT | UFP Technologies | $233.30 -2.5% | $1.81B | 39.1% | 58.8% | — |
| ADUS | Addus HomeCare Corporation | $95.03 +0.85% | $1.77B | 39.6% | 19.4% | — |
| OMCL | Omnicell | $38.68 -0.95% | $1.76B | 58.4% | 42% | — |
| ANAB | AnaptysBio | $59.99 +4.31% | $1.75B | 45.2% | 79.7% | — |
| CMPS | COMPASS Pathways | $12.63 +0.8% | $1.7B | 75.8% | 83% | — |
| RXRX | Recursion Pharmaceuticals | $3.18 -1.55% | $1.69B | 108.9% | 9.3% | — |
| INVA | Innoviva | $22.67 +0.8% | $1.67B | 56.6% | 71.3% | — |
| VIR | Vir Biotechnology, Inc. | $9.57 +4.48% | $1.61B | 125.2% | 72.2% | — |
| DRW3.DE | Draegerwerk | $84.10 -0.24% | $1.58B | 20.7% | 58.5% | — |
| NVCR | NovoCure | $13.61 -4.69% | $1.58B | 91% | 41.6% | — |
| ARDX | Ardelyx | $6.37 +5.29% | $1.57B | 155.9% | 58.7% | — |
| HCSG | Healthcare Services Group, Inc. | $22.54 -1.74% | $1.55B | 16.2% | 84.2% | — |
| NVAX | Novavax | $9.00 -1.42% | $1.48B | 56.8% | 49.1% | — |
| FTRE | Fortrea Holdings Inc. | $15.56 +1.63% | $1.47B | 4.2% | 78.3% | — |
| NEO | NeoGenomics, Inc. | $11.20 +0.63% | $1.46B | 34.4% | 71.8% | — |
| STAA | STAAR Surgical Company | $28.83 -1% | $1.44B | 2.9% | 65.3% | — |
| FAE.MC | Faes Farma | $4.57 +0.22% | $1.42B | 18% | 35.1% | — |
| IART | Integra LifeSciences Holdings C | $17.60 +0.11% | $1.37B | -1% | 92.7% | — |
| PRGO | Perrigo Company plc | $9.60 -6.34% | $1.33B | 71.9% | 1.9% | — |
| ATEC | Alphatec Holdings | $8.55 -2.95% | $1.31B | 95.6% | 10.5% | — |
| AHCO | AdaptHealth Corp. | $9.66 +0.1% | $1.31B | 44.9% | 29.8% | — |
| PAHC | Phibro Animal Health Corporatio | $31.07 -2.45% | $1.26B | 46.8% | 20.5% | — |
| ENOV | Enovis Corporation | $21.30 -3.05% | $1.23B | 98.6% | 4.6% | — |
| BLFS | BioLife Solutions, Inc. | $24.90 -4.38% | $1.22B | 29.7% | 59.9% | — |
| MNKD | MannKind Corporation | $3.89 -1.27% | $1.2B | 95.2% | 38.8% | — |
| INSP | Inspire Medical Systems, Inc. | $41.35 -2.96% | $1.19B | 26.2% | 2.3% | — |
| AMN | AMN Healthcare Services Inc | $30.34 -2.07% | $1.18B | -7.2% | 84.7% | — |
| AVNS | Avanos Medical, Inc. | $24.90 -0.16% | $1.17B | — | 96.4% | — |
| SDGR | Schrodinger | $15.23 -3.36% | $1.14B | 37.1% | 33.5% | — |
| COLL | Collegium Pharmaceutical, Inc. | $33.45 -0.27% | $1.08B | 62.4% | 19.7% | — |
| OPK | OPKO Health | $1.43 +0.7% | $1.08B | 162.9% | 72.6% | — |
| PSNL | Personalis | $10.17 -3.51% | $1.07B | 6.8% | 72.8% | — |
| CRVS | Corvus Pharmaceuticals | $12.56 +5.46% | $1.06B | 165.4% | 38.5% | — |
| XNCR | Xencor | $14.01 +10.84% | $1.04B | 103.4% | 60.2% | — |
| AZTA | Azenta, Inc. | $22.27 -4.46% | $1.03B | 17.7% | 24.6% | — |
| EUZ.DE | Eckert and Ziegler | $15.81 +1.61% | $989.3M | 39.8% | 25.2% | — |
| TNDM | Tandem Diabetes Care | $14.34 -6.27% | $982.7M | 106.3% | 22.2% | — |
| CNMD | Conmed Corporation | $32.54 -0.12% | $979.8M | 21.7% | 4.4% | — |
| AORT | Artivion, Inc. | $20.13 -5% | $977.2M | 108.6% | 3.3% | — |
| USPH | US Physical Therapy | $62.51 -1.28% | $951.3M | 49.8% | 12.2% | — |
| PCRX | Pacira BioSciences, Inc. | $22.71 +1.7% | $893.6M | 30.6% | 44.2% | — |
| CBAV.MC | Clinica Baviera | $55.60 -0.71% | $891M | — | 73.3% | — |
| QDEL | QuidelOrtho Corporation | $12.37 -9.51% | $843.5M | 50.6% | 9.5% | — |
| CERT | Certara | $5.34 -3.61% | $830.7M | 40.1% | 9.4% | — |
| EVT.DE | Evotec | $4.67 +0.86% | $829.4M | 38% | 17.6% | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $18.33 -2.55% | $808.2M | 24.6% | 11.5% | — |
| INMD | InMode | $13.21 -1.42% | $759.3M | 8.5% | 12.2% | — |
| HSTM | HealthStream | $25.36 -1.09% | $740.9M | 26.2% | 57.8% | — |
| LBIRD.PA | Lumibird | $24.20 -1.83% | $534M | 21.9% | 71% | — |
| CTKB | Cytek Biosciences, Inc. | $3.86 +2.39% | $498.5M | 47.3% | 29.3% | — |
| CCCC | C4 Therapeutics | $4.12 -0.72% | $455.5M | 223.6% | 85.2% | — |
| EOLS | Evolent Health | $6.59 -0.6% | $434M | 122.6% | 43.1% | — |
| EDIT | Editas Medicine | $2.80 +4.09% | $429.7M | 106.4% | 39.6% | — |
| WEAV | Weave Communications | $5.16 -0.77% | $410.6M | 69.6% | 18.9% | — |
| PACB | Pacific Biosciences | $1.32 -5.71% | $410M | 86.2% | 14% | — |
| REG1V.HE | Revenio Group | $12.62 +0.8% | $367.1M | 53.5% | 1.8% | — |
| FYB.DE | Formycon | $19.60 -0.71% | $346.4M | 91.8% | 24.5% | — |
| PRLD | Prelude Therapeutics | $4.32 +0% | $344.1M | 85.2% | 74.5% | — |
| TMCI | Treace Medical Concepts | $4.01 -4.3% | $260.1M | -0.3% | 43% | — |
| FATE | Fate Therapeutics | $2.15 +2.87% | $250.6M | 151.7% | 62.9% | — |
| RNA | Avidity Biosciences | $12.94 +2.21% | $221.3M | 93.2% | 28.7% | — |
| SBS.DE | Stratec | $18.16 -0.11% | $220.8M | 39.9% | 11.1% | — |
| EMBC | Embecta Corp | $3.03 -2.57% | $179.8M | 32% | 2% | — |
| CRBU | Caribou Biosciences | $1.64 +0% | $162.7M | 631.7% | 18.8% | — |
| HYPR | Hyperfine | $1.49 -6.88% | $147.9M | 45.4% | 53.2% | — |
| AMWL | Amwell | $8.22 -2.49% | $137.3M | -8.8% | 72.2% | — |
| VXRT | Vaxart | $0.53 -3.81% | $128.3M | 466% | 46.6% | — |
| HCAT | Health Catalyst | $1.72 -1.15% | $127.1M | 1.7% | 24.1% | — |
| NNOX | Nano-X Imaging | $1.62 -2.99% | $112.7M | 344.4% | 0.7% | — |
| SEER | Seer Bio | $1.76 +1.15% | $96.8M | 127.3% | 14.5% | — |
| TELA | Tela Bio | $0.81 +0.5% | $36M | 179.5% | 17.9% | — |
| CTSO | Cytosorbents Corporation | $0.41 -5.77% | $25.9M | 596.1% | 4.2% | — |
| MARI.VI | Marinomed Biotech | $9.10 -3.19% | $18.2M | 449.5% | 4% | — |
Analyse et contexte
Ce filtre sectoriel affiche actuellement 131 actions du segment sélectionné — mis à jour quotidiennement. Le PER moyen est de 37.6x. La croissance moyenne du chiffre d'affaires est de 18.7%. Les secteurs traversent des phases cycliques fortement corrélées aux facteurs macroéconomiques — taux d'intérêt, croissance du PIB, prix des matières premières et environnement réglementaire animent la dynamique sectorielle. Les analystes voient un potentiel moyen de 68.8% sur ces titres. Comparez les ratios à la moyenne du secteur pour identifier les sur- et sous-évaluations relatives. La concentration sectorielle augmente le risque du portefeuille — maintenez une diversification adéquate entre industries et modèles économiques.
Prêt à investir ?
Comparez les meilleurs courtiers pour les actions américaines et européennes — frais, plateformes et types de compte côte à côte.
Comparer les courtiers →